[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial ; volume:50 ; number:7 ; day:24 ; month:2 ; year:2023 ; pages:1929-1939 ; date:6.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 7 (24.2.2023), 1929-1939, 6.2023
- Creator
-
Adams, H.
Garde, E. M. W. van de
Vugts, D. J.
Grutters, J. C.
Oyen, Wim. J.G
Keijsers, R. G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06143-1
- URN
-
urn:nbn:de:101:1-2023090912144504453230
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Adams, H.
- Garde, E. M. W. van de
- Vugts, D. J.
- Grutters, J. C.
- Oyen, Wim. J.G
- Keijsers, R. G.
- SpringerLink (Online service)
Other Objects (12)
Interstitial pneumonitis following intrapleural chemotherapy
Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature
Histopathological findings in patients with refractory nonfibrotic hypersensitivity pneumonitis
Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Refractory Pulmonary Interstitial Emphysema in Extreme Premature Newborn
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia
Interstitial pneumonitis following intrapleural chemotherapy
Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature
Histopathological findings in patients with refractory nonfibrotic hypersensitivity pneumonitis
Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Refractory Pulmonary Interstitial Emphysema in Extreme Premature Newborn
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia
Interstitial pneumonitis following intrapleural chemotherapy
Desvenlafaxine-Induced Interstitial Pneumonitis: A Case Report
Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature
Histopathological findings in patients with refractory nonfibrotic hypersensitivity pneumonitis
Pulmonary Lymphangitis Carcinomatosa Mimicking Immunotherapy-Related Interstitial Pneumonitis: A Case Report
Interstitial lung disease in patients with scleroderma - Treatment with rituximab
Refractory Pulmonary Interstitial Emphysema in Extreme Premature Newborn
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS